Find policies, billing codes, payers, states, and providers
CPT 95970: Electronic Analysis of Implanted Neurostimulator Pulse Generator
CPT code 95970 denotes a physician-performed electronic analysis of an implanted neurostimulator pulse generator/transmitter to confirm device functionality without performing reprogramming. This service is clinically important given the growing use of implantable neurostimulation for conditions such as Parkinson's disease, epilepsy, chronic pain, and movement disorders; timely device checks support patient safety and continuity of therapy. Major national payers included in this coverage overview are Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise explanation of the service and typical delivery settings, comparisons to closely related device-analysis codes, and a summary of common clinical indications tied to relevant ICD-10 diagnoses. The publication highlights key billing and coding considerations such as the distinction between analysis-only services and those that include programming, common service sites, and how the code fits within device-management workflows. This resource is intended for billing professionals, practice managers, and clinicians who need a clear, national-level reference for documentation and coding classification of implanted neurostimulator electronic analysis.
Customize your policy alerts
Sign up for cpt 95970 policy alerts
Get alerted when payer policies referencing 95970 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 95970 describes an electronic analysis of a previously implanted neurostimulator pulse generator/transmitter performed by a physician or other qualified healthcare professional to verify device function. The service involves interrogation and assessment of device parameters and performance; it does not include reprogramming or adjustment of the device.
Service Type: Device function analysis / Remote or in‑person device interrogation
Typical Site of Service: Outpatient clinic or device clinic setting; may also occur in an ambulatory surgery center or hospital outpatient department when provided as a nonprocedural device check
National Reimbursement Benchmarks
Commercial averages are meaningfully higher than Medicare for CPT 95970: Blue Cross Blue Shield and BUCA show substantially elevated means versus Medicare’s mean of $20.2. BUCA’s mean of $127.4 sits well above Medicare, and Blue Cross Blue Shield’s mean of $195.5 is highest among listed commercial payers, highlighting a clear commercial–Medicare gap in national mean rates.
Dispersion (P75 minus P25) varies across payers: Blue Cross Blue Shield displays the widest interquartile spread at $71.0 ($235.4 − $164.5), indicating greater variability in negotiated commercial rates. Aetna and UnitedHealth Group show moderate spreads of $25.0 ($42.0 − $18.4) and $27.0 ($50.3 − $22.8), respectively. Cigna’s spread is $28.8 ($51.2 − $23.2). BUCA’s interquartile spread is $51.8 ($155.0 − $103.2), and Medicare’s spread is narrow at $2.0 ($21 − $19), making Medicare the tightest payer by this measure.